Diagnostic performance of DSC perfusion MRI to distinguish tumor progression and treatment-related changes: a systematic review and meta-analysis is a research paper published in Neuro-Oncology Advances (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA199111
National Cancer Institute
Grant: 1K08CA237809-01A1
Defining the Hypoxic Immunosuppressive Microenvironment as a Biomarker of Therapy Efficacy in Glioblastoma Using Iron Oxide Enhanced FMISO PET/MRI
NCI NIH HHS
Grant: R01 CA199111
NCI NIH HHS
Grant: K08 CA237809
NCI NIH HHS
Grant: L30 CA220897
National Institutes of Health
Grant: 5R01CA199111-35
Opening of the Blood-Brain Barrier to Antitumor Agents
Jonathan D. Lewis Foundation
Walter S. and Lucienne Driskill Foundation
FWCI
0.72
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals